Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
Canonic
Canonic Overview
Canonic aims to develop and bring to market medical-grade cannabis using a genomic approach. The company will initially focus on creating improved cannabis varieties, focusing on yield, stability, and specific metabolite composition.
The company is a subsidiary of Evogene. Canonics development efforts will be based on the utilization of Evogenes computational predictive biology platform, which has already demonstrated success in addressing similar objectives for other crops.